List of Tables
Table 1. Global Gene Therapy Viral Vector and Plasmid DNA Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gene Therapy Viral Vector and Plasmid DNA Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Gene Therapy Viral Vector and Plasmid DNA Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gene Therapy Viral Vector and Plasmid DNA Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gene Therapy Viral Vector and Plasmid DNA Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gene Therapy Viral Vector and Plasmid DNA, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gene Therapy Viral Vector and Plasmid DNA, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gene Therapy Viral Vector and Plasmid DNA, Product Type & Application
Table 12. Global Key Manufacturers of Gene Therapy Viral Vector and Plasmid DNA, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene Therapy Viral Vector and Plasmid DNA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Viral Vector and Plasmid DNA as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gene Therapy Viral Vector and Plasmid DNA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gene Therapy Viral Vector and Plasmid DNA Sales by Region (2020-2025) & (K Units)
Table 18. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Region (2020-2025)
Table 19. Global Gene Therapy Viral Vector and Plasmid DNA Sales by Region (2026-2031) & (K Units)
Table 20. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Region (2026-2031)
Table 21. Global Gene Therapy Viral Vector and Plasmid DNA Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Region (2020-2025)
Table 23. Global Gene Therapy Viral Vector and Plasmid DNA Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Region (2026-2031)
Table 25. North America Gene Therapy Viral Vector and Plasmid DNA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2020-2025) & (K Units)
Table 27. North America Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2026-2031) & (K Units)
Table 28. North America Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gene Therapy Viral Vector and Plasmid DNA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2020-2025) & (K Units)
Table 32. Europe Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2026-2031) & (K Units)
Table 33. Europe Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapy Viral Vector and Plasmid DNA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) by Type (2020-2025)
Table 51. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) by Type (2026-2031)
Table 52. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Type (2020-2025)
Table 53. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Type (2026-2031)
Table 54. Global Gene Therapy Viral Vector and Plasmid DNA Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gene Therapy Viral Vector and Plasmid DNA Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Type (2020-2025)
Table 57. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Type (2026-2031)
Table 58. Global Gene Therapy Viral Vector and Plasmid DNA Price (US$/Unit) by Type (2020-2025)
Table 59. Global Gene Therapy Viral Vector and Plasmid DNA Price (US$/Unit) by Type (2026-2031)
Table 60. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) by Application (2020-2025)
Table 61. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) by Application (2026-2031)
Table 62. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Application (2020-2025)
Table 63. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Application (2026-2031)
Table 64. Global Gene Therapy Viral Vector and Plasmid DNA Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gene Therapy Viral Vector and Plasmid DNA Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Application (2020-2025)
Table 67. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Application (2026-2031)
Table 68. Global Gene Therapy Viral Vector and Plasmid DNA Price (US$/Unit) by Application (2020-2025)
Table 69. Global Gene Therapy Viral Vector and Plasmid DNA Price (US$/Unit) by Application (2026-2031)
Table 70. Lonza Company Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Lonza Gene Therapy Viral Vector and Plasmid DNA Product
Table 74. Lonza Recent Developments/Updates
Table 75. Merck KGaA Company Information
Table 76. Merck KGaA Description and Business Overview
Table 77. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Product
Table 79. Merck KGaA Recent Developments/Updates
Table 80. Thermo Fisher Scientific Company Information
Table 81. Thermo Fisher Scientific Description and Business Overview
Table 82. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Product
Table 84. Thermo Fisher Scientific Recent Developments/Updates
Table 85. Charles River Laboratories Company Information
Table 86. Charles River Laboratories Description and Business Overview
Table 87. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Product
Table 89. Charles River Laboratories Recent Developments/Updates
Table 90. Catalent Company Information
Table 91. Catalent Description and Business Overview
Table 92. Catalent Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Catalent Gene Therapy Viral Vector and Plasmid DNA Product
Table 94. Catalent Recent Developments/Updates
Table 95. WuXi AppTec Company Information
Table 96. WuXi AppTec Description and Business Overview
Table 97. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Product
Table 99. WuXi AppTec Recent Developments/Updates
Table 100. FUJIFILM Company Information
Table 101. FUJIFILM Description and Business Overview
Table 102. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Product
Table 104. FUJIFILM Recent Developments/Updates
Table 105. GenScript Biotech Company Information
Table 106. GenScript Biotech Description and Business Overview
Table 107. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Product
Table 109. GenScript Biotech Recent Developments/Updates
Table 110. Takara Bio Company Information
Table 111. Takara Bio Description and Business Overview
Table 112. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Product
Table 114. Takara Bio Recent Developments/Updates
Table 115. Oxford Biomedica Company Information
Table 116. Oxford Biomedica Description and Business Overview
Table 117. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Product
Table 119. Oxford Biomedica Recent Developments/Updates
Table 120. Novartis Company Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Novartis Gene Therapy Viral Vector and Plasmid DNA Product
Table 124. Novartis Recent Developments/Updates
Table 125. Precision Biosciences Company Information
Table 126. Precision Biosciences Description and Business Overview
Table 127. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Product
Table 129. Precision Biosciences Recent Developments/Updates
Table 130. Bluebird Bio Company Information
Table 131. Bluebird Bio Description and Business Overview
Table 132. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Product
Table 134. Bluebird Bio Recent Developments/Updates
Table 135. Sartorius AG Company Information
Table 136. Sartorius AG Description and Business Overview
Table 137. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Product
Table 139. Sartorius AG Recent Developments/Updates
Table 140. Danaher Company Information
Table 141. Danaher Description and Business Overview
Table 142. Danaher Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Danaher Gene Therapy Viral Vector and Plasmid DNA Product
Table 144. Danaher Recent Developments/Updates
Table 145. SIRON Biotech Company Information
Table 146. SIRON Biotech Description and Business Overview
Table 147. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Product
Table 149. SIRON Biotech Recent Developments/Updates
Table 150. VGXI Company Information
Table 151. VGXI Description and Business Overview
Table 152. VGXI Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. VGXI Gene Therapy Viral Vector and Plasmid DNA Product
Table 154. VGXI Recent Developments/Updates
Table 155. Waisman Biomanufacturing Company Information
Table 156. Waisman Biomanufacturing Description and Business Overview
Table 157. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Product
Table 159. Waisman Biomanufacturing Recent Developments/Updates
Table 160. Kaneka Eurogentec Company Information
Table 161. Kaneka Eurogentec Description and Business Overview
Table 162. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Product
Table 164. Kaneka Eurogentec Recent Developments/Updates
Table 165. PlasmidFactory Company Information
Table 166. PlasmidFactory Description and Business Overview
Table 167. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Product
Table 169. PlasmidFactory Recent Developments/Updates
Table 170. ATUM Company Information
Table 171. ATUM Description and Business Overview
Table 172. ATUM Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. ATUM Gene Therapy Viral Vector and Plasmid DNA Product
Table 174. ATUM Recent Developments/Updates
Table 175. Addgene Company Information
Table 176. Addgene Description and Business Overview
Table 177. Addgene Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Addgene Gene Therapy Viral Vector and Plasmid DNA Product
Table 179. Addgene Recent Developments/Updates
Table 180. Cell and Gene Therapy Catapult Company Information
Table 181. Cell and Gene Therapy Catapult Description and Business Overview
Table 182. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Product
Table 184. Cell and Gene Therapy Catapult Recent Developments/Updates
Table 185. Batavia biosciences Company Information
Table 186. Batavia biosciences Description and Business Overview
Table 187. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Product
Table 189. Batavia biosciences Recent Developments/Updates
Table 190. Altogen Biosystems Company Information
Table 191. Altogen Biosystems Description and Business Overview
Table 192. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Product
Table 194. Altogen Biosystems Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Gene Therapy Viral Vector and Plasmid DNA Distributors List
Table 198. Gene Therapy Viral Vector and Plasmid DNA Customers List
Table 199. Gene Therapy Viral Vector and Plasmid DNA Market Trends
Table 200. Gene Therapy Viral Vector and Plasmid DNA Market Drivers
Table 201. Gene Therapy Viral Vector and Plasmid DNA Market Challenges
Table 202. Gene Therapy Viral Vector and Plasmid DNA Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gene Therapy Viral Vector and Plasmid DNA
Figure 2. Global Gene Therapy Viral Vector and Plasmid DNA Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy Viral Vector and Plasmid DNA Market Share by Type: 2024 & 2031
Figure 4. Viral Vectors Product Picture
Figure 5. Plasmid DNA Product Picture
Figure 6. Global Gene Therapy Viral Vector and Plasmid DNA Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapy Viral Vector and Plasmid DNA Market Share by Application: 2024 & 2031
Figure 8. Cell and Gene Therapy
Figure 9. Vaccine Development
Figure 10. Research
Figure 11. Global Gene Therapy Viral Vector and Plasmid DNA Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gene Therapy Viral Vector and Plasmid DNA Market Size (2020-2031) & (US$ Million)
Figure 13. Global Gene Therapy Viral Vector and Plasmid DNA Sales (2020-2031) & (K Units)
Figure 14. Global Gene Therapy Viral Vector and Plasmid DNA Average Price (US$/Unit) & (2020-2031)
Figure 15. Gene Therapy Viral Vector and Plasmid DNA Report Years Considered
Figure 16. Gene Therapy Viral Vector and Plasmid DNA Sales Share by Manufacturers in 2024
Figure 17. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Gene Therapy Viral Vector and Plasmid DNA Players: Market Share by Revenue in Gene Therapy Viral Vector and Plasmid DNA in 2024
Figure 19. Gene Therapy Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Gene Therapy Viral Vector and Plasmid DNA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Country (2020-2031)
Figure 22. North America Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Country (2020-2031)
Figure 23. United States Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Country (2020-2031)
Figure 26. Europe Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Country (2020-2031)
Figure 27. Germany Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Region (2020-2031)
Figure 34. China Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Country (2020-2031)
Figure 42. Latin America Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Gene Therapy Viral Vector and Plasmid DNA Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Gene Therapy Viral Vector and Plasmid DNA by Type (2020-2031)
Figure 52. Global Revenue Market Share of Gene Therapy Viral Vector and Plasmid DNA by Type (2020-2031)
Figure 53. Global Gene Therapy Viral Vector and Plasmid DNA Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Gene Therapy Viral Vector and Plasmid DNA by Application (2020-2031)
Figure 55. Global Revenue Market Share of Gene Therapy Viral Vector and Plasmid DNA by Application (2020-2031)
Figure 56. Global Gene Therapy Viral Vector and Plasmid DNA Price (US$/Unit) by Application (2020-2031)
Figure 57. Gene Therapy Viral Vector and Plasmid DNA Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
